Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,000
Closed -$593K 1844
2025
Q4
$593K Hold
6,000
﹤0.01% 671
2025
Q3
$509K Hold
6,000
﹤0.01% 632
2025
Q2
$409K Buy
+6,000
New +$380K 0.01% 1058
2023
Q1
Sell
-100
Closed -$8.03K 1667
2022
Q4
$8.03K Hold
100
﹤0.01% 1297
2022
Q3
$7K Sell
100
-2,600
-96% -$192K ﹤0.01% 1404
2022
Q2
$206K Buy
+2,700
New +$205K ﹤0.01% 1277
2020
Q2
Sell
-11,800
Closed -$865K 740
2020
Q1
$865K Buy
+11,800
New +$891K 0.04% 231

Other funds holding INCY

Centiva Capital's INCY Position: Q2 2025 in Review

Centiva Capital sold out of Incyte (INCY) in Q2 2025, closing a stake of 8,024 shares — an estimated $508K sold.

Centiva Capital first reported a position in INCY in Q4 2019 and held it in 13 quarters. The position peaked at $2.54M in Q2 2021. 658 funds tracked by Wall St. Rank hold INCY as of Q2 2025.

  • Centiva Capital reported no remaining Incyte position as of Q2 2025 after selling out during the quarter.
  • Centiva Capital sold 8,024 Incyte shares in Q2 2025, an estimated $508K.
  • Centiva Capital first reported a position in Incyte in Q4 2019 and held it in 13 quarters.
  • Centiva Capital's Incyte position peaked at $2.54M in Q2 2021.
  • 658 funds tracked by Wall St. Rank held Incyte as of Q2 2025.

Based on Centiva Capital's 13F filing for Q2 2025, filed 13 Aug 2025.